Improvement of risk assessment by integrating toxicological and epidemiological approaches: the case of isoflavones

Biochemistry, Genetics and Molecular Biology

• Isoflavone 100%
• Glucuronide 44%
• Gene Expression 32%
• Aglycone 28%
• Peripheral Blood Mononuclear Cell 20%
• Metabolic Pathway 12%
• Intervention Study 12%
• Daidzein 12%
• Species Difference 12%
• Genistein 12%
• Target Tissue 12%
• Metabolite 8%
• Glucuronidation 8%
• Postmenopause 8%
• Glucosidase 8%
• Gene Expression Profiling 4%
• Gene Expression Data 4%
• Hydrolase 4%
• Animal Model 4%
• Intestinal Mucosal Barrier 4%
• Estradiol 4%
• Phlorizin 4%
• Sulfation 4%
• Glucocerebrosidase 4%
• Enzyme 4%
• Catalytic Efficiency 4%
• Animal Experiment 4%
• Body Weight 4%
• Biological Activity 4%
• Reporter Gene 4%
• Estrogen Receptor 4%
• Low Drug Dose 4%
• Sulfate 4%
• Cancer Cell 4%
• Glucosylceramidase 4%
• Lactase 4%
• Genistin 4%
• Glycoside 4%
• Daidzin 4%

Neuroscience

• Isoflavone 100%
• Glucuronide 44%
• Gene Expression 36%
• Aglycone 28%
• Peripheral Blood Mononuclear Cell 20%
• In Vitro 16%
• Genistein 12%
• Metabolic Pathway 12%
• Daidzein 12%
• Glucuronidation 8%
• Adipose Tissue 8%
• Glucosidase 8%
• Cell Line 4%
• In Vivo 4%
• Diethylstilbestrol 4%
• Sulfation 4%
• Steroid Hormone 4%
• Transcriptomics 4%
• Reporter Gene 4%
• Glucosylceramidase 4%
• Glycosylceramidase 4%
• Intestine Enzyme 4%
• Estrogen Receptor 4%
• Glycoside 4%
• Daidzin 4%
• Genistin 4%

Pharmacology, Toxicology and Pharmaceutical Science

• Soybean 100%
• Glucuronide 47%
• Aglycone 30%
• Isoflavone 17%
• Intervention Study 13%
• Genistein 13%
• Daidzein 13%
• Systemic Circulation 8%
• Glucosidase 8%
• Estrogen Receptor 4%
• Genistin 4%
• Sulfate 4%
• Steroid Hormone 4%
• Intestine Enzyme 4%
• Glucosylceramidase 4%
• Glycosylceramidase 4%
• Biological Marker 4%
• Bioavailability 4%
• Diethylstilbestrol 4%
• Glycoside 4%
• Breast Cancer 4%
• Daidzin 4%